Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:693670.
doi: 10.1155/2014/693670. Epub 2014 Nov 20.

Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment

Roberto José Barone  1 , María Inés Cámpora  1 , Nélida Susana Gimenez  1 , Liliana Ramirez  1 , Sergio Alberto Panese  1 , Mónica Santopietro  1
Affiliations

Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment

Roberto José Barone et al. Int J Nephrol. 2014.

Abstract

For renal replacement therapy, overall survival is more important than the choice of currently available individual therapy. Objectives. To compare patients and technique survival on peritoneal dialysis as first treatment (PDF) versus after previous haemodialysis (HDPD) and other indicators of follow-up. Methods. We prospectively studied 110 incident patients, during the period from August 4, 1993, to June 30, 2012, for patients and technique survival (Kaplan-Meier) (log rank P < 0.05). Results. Groups: (A) PDF: 37 patients, 24 females, age: 52.2 ± 14.9 years old, time at risk: 2123 patient-months (p/m), mean: 57 ± 42 months; (B) HDPD: 73 patients, 42 females, age: 52.45 ± 14.7 years old, time in haemodialysis: 3569.2 (p/m), range: 3-216 months, mean: 49 ± 45 months, time at risk in PD: 3700 (p/m), mean: 51 ± 49 months. Patients' survival: (A) PDF: 100%, 76.6%, 65.6%, and 19.7%; (B) HDPD: 95.4%, 65.6%, 43%, and 43% at 12, 60, 120, and 144 months, respectively, P = 0.34.

Technique: (A) PDF: 100%, 90%, 59.8%, and 24%; (B) HDPD: 94%, 75%, 32%, and 32% at 12, 60, 120, and 144 months, respectively, P = 0.40. Conclusions. Comparable patient and technique survival were observed. Peritoneal dialysis enables a greater extension of renal replacement therapy for patients with serious difficulties continuing with haemodialysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patients survival PDF (green) and HDPD (blue) (log rank P = 0.33).
Figure 2
Figure 2
Technique survival PDF (green) and HDPD (blue) (log rank P = 0.20).
Figure 3
Figure 3
Patients survival PDF (green) and HDPD (anuric) (blue) (log rank P = 0.31).
Figure 4
Figure 4
Technique survival PDF (green) and HDPD (anuric) (blue) (log rank P = 0.48).
Figure 5
Figure 5
Catheters survival PDF (green) and HDPD (blue) (log rank P = 0.62).
See this image and copyright information in PMC

References

    1. Churchill D. N., Taylor D. W., Vas S. I., et al. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Peritoneal Dialysis International. 1989;9(3):159–163. - PubMed
    1. Boyce N. W., Thomson N. M., Atkins R. C. Management of peritonitis complicating continuous ambulatory peritoneal dialysis: an Australian perspective. Peritoneal Dialysis Bulletin. 1987;7(2):93–97.
    1. Buoncristiani U. The Y set with disinfectant is here to stay. Peritoneal Dialysis International. 1989;9(3):149–150. - PubMed
    1. Maiorca R., Cancarini G. C., Cantaluppi A., Scalamogna A., Broccoli R., Graziani G., Brasa S., Ponticelli C. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. The Lancet. 1983;2(8351):642–644. doi: 10.1016/S0140-6736(83)92528-X. - DOI - PubMed
    1. Gokal R., Hutchison A. Dialysis therapies for end-stage renal disease. Seminars in Dialysis. 2002;15(4):220–226. doi: 10.1046/j.1525-139X.2002.00064.x. - DOI - PubMed

LinkOut - more resources